{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:43:03Z","timestamp":1793133783828,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.critrevonc.2010.06.006","type":"journal-article","created":{"date-parts":[[2010,7,24]],"date-time":"2010-07-24T07:02:05Z","timestamp":1279954925000},"page":"84-90","source":"Crossref","is-referenced-by-count":77,"title":["Enteropathy-associated T-cell lymphoma"],"prefix":"10.1016","volume":"79","author":[{"given":"Andr\u00e9s J.M.","family":"Ferreri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Zinzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Govi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano A.","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2010.06.006_bib0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1096-9896(199707)182:3<311::AID-PATH888>3.0.CO;2-U","article-title":"Expression of cytotoxic molecules in intestinal T-cell lymphomas. The German study group on intestinal non-hodgkin lymphoma","volume":"182","author":"Daum","year":"1997","journal-title":"J Pathol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0010","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1053\/j.gastro.2005.02.027","article-title":"Association of celiac disease and intestinal lymphomas and other cancers","volume":"128","author":"Catassi","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0015","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2036.2004.02177.x","article-title":"Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study","volume":"20","author":"Card","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/path.1711770203","article-title":"Non-Hodgkin's lymphoma, coeliac disease, and Epstein\u2013Barr virus: a study of 13 cases of enteropathy-associated T- and B-cell lymphoma","volume":"177","author":"Ilyas","year":"1995","journal-title":"J Pathol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0950-3528(95)90035-7","article-title":"The major complications of coeliac disease","volume":"9","author":"Wright","year":"1995","journal-title":"Baillieres Clin Gastroenterol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood.V94.1.260.413k40_260_264","article-title":"Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population","volume":"94","author":"Bagdi","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0035","first-page":"493","article-title":"Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma","volume":"151","author":"Ashton-Key","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(00)02481-8","article-title":"Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French coeliac disease study group","volume":"356","author":"Cellier","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0045","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0016-5085(98)70530-X","article-title":"Abnormal intestinal intraepithelial lymphocytes in refractory sprue","volume":"114","author":"Cellier","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0050","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bpg.2005.02.001","article-title":"Refractory coeliac disease","volume":"19","author":"Daum","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0016-5085(03)00692-9","article-title":"Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue","volume":"125","author":"Verkarre","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0065-230X(08)61003-9","article-title":"Epstein\u2013Barr virus-associated lymphoproliferative disorders in immunocompromised individuals","volume":"57","author":"Thomas","year":"1991","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00007890-198701000-00008","article-title":"Cancers following cyclosporine therapy","volume":"43","author":"Penn","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0070","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000478-199305000-00001","article-title":"Primary lymphoma of the small intestine. A clinicopathological study of 119 cases","volume":"17","author":"Domizio","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0075","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/blood.V89.2.644","article-title":"Primary non-Hodgkin's lymphoma of the intestine: high prevalence of Epstein\u2013Barr virus in Mexican lymphomas as compared with European cases","volume":"89","author":"Quintanilla-Martinez","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0080","series-title":"Extranodal lymphomas","author":"Isaacson","year":"1994"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0085","first-page":"249","article-title":"Enteropathy associated T cell lymphoma","volume":"30","author":"Wright","year":"1997","journal-title":"Cancer Surv"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0090","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0002-9440(10)65736-7","article-title":"Most CD56+ intestinal lymphomas are CD8+CD5\u2212 T-cell lymphomas of monomorphic small to medium size histology","volume":"153","author":"Chott","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0198-8859(94)00130-I","article-title":"HLA-DRB, -DQA, and -DQB polymorphism in celiac disease and enteropathy-associated T-cell lymphoma. Common features and additional risk factors for malignancy","volume":"43","author":"Howell","year":"1995","journal-title":"Hum Immunol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0100","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","article-title":"Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes","volume":"132","author":"Deleeuw","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0105","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0002-9440(10)64441-0","article-title":"Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma","volume":"161","author":"Zettl","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00292-006-0886-2","article-title":"Enteropathy type T-cell lymphomas: pathology and pathogenesis","volume":"28","author":"Zettl","year":"2007","journal-title":"Pathologe"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2214\/ajr.168.1.8976941","article-title":"Non-Hodgkin's lymphoma of the gastrointestinal tract: radiographic findings","volume":"168","author":"Levine","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0120","first-page":"25","article-title":"Enteropathy-associated T-cell lymphoma presenting with eosinophilia","volume":"61","author":"Hovenga","year":"2003","journal-title":"Neth J Med"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0125","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.WNL.0000066052.84194.6E","article-title":"Enteropathy-associated T-cell lymphoma with initial manifestation in the CNS","volume":"60","author":"Gobbi","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0130","first-page":"1622","article-title":"18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease","volume":"47","author":"Hadithi","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0135","first-page":"1860","article-title":"Report of the committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0140","first-page":"218","article-title":"Clinical staging classification of non-Hodgkin's lymphomas (author's transl)","volume":"153","author":"Musshoff","year":"1977","journal-title":"Strahlentherapie"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0145","first-page":"209","article-title":"A study of gastro-intestinal lymphoma","volume":"5","author":"Blackledge","year":"1979","journal-title":"Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/oxfordjournals.annonc.a058869","article-title":"Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma","volume":"5","author":"Rohatiner","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0155","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","article-title":"Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center","volume":"18","author":"Gale","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0160","first-page":"1361","article-title":"Peripheral T-cell lymphomas of the intestine","volume":"141","author":"Chott","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0165","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1200\/JCO.1994.12.8.1673","article-title":"Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group","volume":"12","author":"d\u2019Amore","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0170","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000204887","article-title":"Direct comparison of peripheral T-cell lymphomas with their B-cell counterpart","volume":"85","author":"Liang","year":"1991","journal-title":"Acta Haematol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0175","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/bjc.1993.141","article-title":"Primary gastrointestinal non-Hodgkin's lymphoma: a review of 175 British National Lymphoma Investigation cases","volume":"67","author":"Morton","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0180","first-page":"191","article-title":"A single-center report on clinical features and treatment response in patients with intestinal T cell non-Hodgkin's lymphomas","volume":"16","author":"Novakovic","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0185","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00277-004-0953-9","article-title":"Enteropathy-associated T-cell lymphoma without a prior diagnosis of coeliac disease: diagnostic dilemmas and management options","volume":"84","author":"Honemann","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0190","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1200\/JCO.2003.06.026","article-title":"Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma","volume":"21","author":"Daum","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/10428199109068062","article-title":"Gastrointestinal non-Hodgkin's lymphoma","volume":"4","author":"Stewart","year":"1991","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0200","first-page":"305","article-title":"Primary intestinal lymphoma: clinical and therapeutic features of 32 patients","volume":"82","author":"Zinzani","year":"1997","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0205","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1200\/JCO.1994.12.7.1375","article-title":"Primary small-intestinal lymphomas in Taiwan: immunoproliferative small-intestinal disease and nonimmunoproliferative small-intestinal disease","volume":"12","author":"Shih","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0210","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2169\/internalmedicine.41.734","article-title":"CD56 positive intestinal T-cell lymphoma: treatment with high dose chemotherapy and autologous peripheral blood stem cell transplantation","volume":"41","author":"Okuda","year":"2002","journal-title":"Intern Med"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0215","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.dld.2007.03.009","article-title":"Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma","volume":"39","author":"Al-Toma","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0220","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s10620-006-8013-z","article-title":"Successful treatment of enteropathy-associated T cell lymphoma with autologous stem cell transplant","volume":"51","author":"Rongey","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2141.2006.06371.x","article-title":"Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma","volume":"136","author":"Bishton","year":"2007","journal-title":"Br J Haematol"},{"issue":"Suppl. 2","key":"10.1016\/j.critrevonc.2010.06.006_bib0230","first-page":"437","article-title":"Dose-dense induction followed by autologous stem cell transplant (ASCT) leads to sustained remissions in a large fraction of patients with previously untreated peripheral T-cell lymphomas (PTCLS)\u2014overall and subtype-specific results of a phase II study from the Nordic Lymphoma Group","volume":"94","author":"d\u2019Amore","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0235","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2009-07-231324","article-title":"Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation","volume":"115","author":"Sieniawski","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0240","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/00855920410014605","article-title":"Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment","author":"Meijer","year":"2004","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0245","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2006-08-042820","article-title":"Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells","volume":"109","author":"Al-Toma","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0250","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1200\/JCO.2009.22.6688","article-title":"Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms","volume":"27","author":"Ravandi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0255","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2007-02-074641","article-title":"Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial","volume":"110","author":"Gallamini","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0260","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00280-007-0469-9","article-title":"Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study","volume":"60","author":"Kim","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0265","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2141.2008.07202.x","article-title":"Efficacy of alemtuzumab and gemcitabine in a patient with enteropathy-type T-cell lymphoma","volume":"142","author":"Soldini","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0270","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1056\/NEJMc053129","article-title":"Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma","volume":"354","author":"Vivas","year":"2006","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.critrevonc.2010.06.006_bib0275","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2036.2007.03478.x","article-title":"Review article: stem cell transplantation for the treatment of gastrointestinal diseases\u2014current applications and future perspectives","volume":"26","author":"Al-Toma","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0280","first-page":"S46","article-title":"Extranodal peripheral T-cell and NK-cell neoplasms","volume":"111","author":"Jaffe","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0285","first-page":"324","article-title":"Lymphoma of the gastrointestinal tract","volume":"26","author":"Crump","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1016\/j.critrevonc.2010.06.006_bib0290","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/annonc\/mdn726","article-title":"Alemtuzumab and DHAP (A-DHAP) is effective for relapsed peripheral T-cell lymphoma, unspecified: interim results of a phase II prospective study","volume":"20","author":"Kim","year":"2009","journal-title":"Ann Oncol"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842810001496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842810001496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T09:20:45Z","timestamp":1591521645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842810001496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1040842810001496"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2010.06.006","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}